RVPH Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 121087 min ago

@ $4.65

Wydano: 13 vas. 2024 @ 19:23

Zwrot: -38.06%

Poprzedni sygnał: vas. 13 - 16:32

Poprzedni sygnał: Sprzedaż

Zwrot: 4.26 %

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 22:23):

Stats
Dzisiejszy wolumen	149 467
Średni wolumen	254 221
Kapitalizacja rynkowa	80.41M
EPS	$0 ( 2024-04-04 )
Następna data zysków	( $-0.280 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.750
ATR14	$0.00900 (0.31%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-20	Saxena Parag	Buy	585 366	Pre-Funded Warrant
2023-11-20	Saxena Parag	Buy	585 366	Common Stock Warrant (right to buy)
2023-11-13	Funtleyder Leslie D.	Buy	8 200	Stock Option (right to buy)
2023-11-13	Patel Purav	Buy	8 200	Stock Option (right to buy)
2023-11-13	Saxena Parag	Buy	8 200	Stock Option (right to buy)

INSIDER POWER
100.00
Last 72 transactions
Buy: 9 383 157 \| Sell: 2 515 186

Wolumen Korelacja

Długi: 0.06 (neutral)

Krótki: 0.21 (neutral)

Signal:(59.646) Neutral

Reviva Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
RUN	0.875
LAZR	0.854
CLLS	0.849
MAXN	0.841
MLTX	0.835
AFRM	0.834
MDGS	0.833
DLTH	0.833
FCEL	0.832
RDUS	0.829

10 Najbardziej negatywne korelacje
ISNS	-0.839
APOP	-0.832

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Reviva Pharmaceuticals Korelacja - Waluta/Towar

0.54
( weak )

0.69
( moderate )

0.00
( neutral )

-0.07
( neutral )

0.14
( neutral )

-0.68
( moderate negative )

Reviva Pharmaceuticals Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-1.250

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-1.250

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.662

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.240

Financial Reports:

No articles found.

Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.